Preclinical Trusted Source PubMed Central Go to source studies in mice models of ulcerative colitis suggest that GLP-1 has a protective effect on the gut by reducing proinflammatory mediators
Repeated injections of impure peptides can trigger immune responses
FDA Telehealth Warning Letters In early March 2026, the FDA reportedly issued warning letters to multiple telehealth companies regarding compounded GLP-1 marketing practices, with concerns including misleading marketing claims, implications of equivalence with FDA-approved drugs, and obscuring product sourcing
Medical Solutions for Safe, Effective Weight Loss Weight loss medication management at Premier Physicians Weight Loss & Wellness is a physician-supervised program that uses FDA-approved prescription medications, including GLP-1 receptor agonists such as semaglutide and tirzepatide, to help patients achieve sustainable weight loss
it does not predict drug response, select a medication, or recommend a dose